STE · 8-K · 20260805PR053412

Acquisition / Partnership / Divestiture

STERIS plc · 2026-08-05 · Importance 34 · Surprise 42

STERIS announced a targeted restructuring plan to consolidate formulated-chemistries manufacturing and distribution at a new Center of Excellence in North Carolina. The initiative is intended to accelerate innovation, expand capacity, and optimize the U.S. chemistries manufacturing and distribution network. The plan anticipates closing chemistry manufacturing and distribution facilities in St. Louis, Missouri, and Plymouth, Minnesota. STERIS expects approximately $55 million to $70 million of pre-tax restructuring charges, including $40 million to $50 million of cash expenditures and $15 million to $20 million of non-cash charges, with completion anticipated during fiscal 2030.